Drug Database
AB

abuse-deterrent extended release tablet technology

✓ Approved

Inspirion Delivery Technologies · 治疗药物

什么是 abuse-deterrent extended release tablet technology?

abuse-deterrent extended release tablet technology 是一种治疗药物,由Inspirion Delivery Technologies研发。该药已获批,用于治疗相关适应症,给药途径:Others。

药物档案

公司Inspirion Delivery Technologies
给药途径Others
状态Approved

治疗适应症

abuse-deterrent extended release tablet technology 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Surgical and medical proceduresOral appliance application✓ Approved

相关研究文献

PubMedJournal of child sexual abuse2026-11-19

Sexual Satisfaction in Two-Spirit, Transgender, and Non-Binary Survivors of Childhood Sexual Abuse.

Cheek Oliver O, Menard Amy A

Existing research on the impact of childhood sexual abuse (CSA) on adult sexual satisfaction has focused on the experiences of cisgender, heterosexual survivors. However, despite a high rate of victimization within the community, the long-term impacts on sexual wellbeing for two-spirit, transgender, and non-binary survivors (2STNB) have been neglected. The objectives of this study were to determine the impact of CSA on sexual satisfaction in a sample of 2STNB adults as well as factors that may influence this relationship. A community sample of 317 individuals was recruited through social media posts to complete an online survey, including measures of adverse childhood experiences, severity of CSA, sexual satisfaction, symptoms of post-traumatic stress disorder (PTSD), experiences of intimate partner violence (IPV), and demographic questions. Results indicated that sexual satisfaction scores were not significantly related to CSA history and did not differ based on survivors' gender identities. Significant relationships were observed between the severity of abuse and PTSD scores, and the severity of abuse and IPV scores. Clinicians are nevertheless advised to carefully assess for CSA and to assess sexual satisfaction with 2STNB individuals and couples. Further research on the long-term effects of these experiences on the sexuality of 2STNB survivors would be valuable.

PMID 43053553
阅读全文 →
PubMedEye (London, England)2026-11-19

Outcomes of cataract surgery in eyes with vitreomacular traction: a retrospective cohort study.

Kilian Raphael R, Saihan Zubin Z, Maurino Vincenzo V

To evaluate the anatomical and visual outcomes after uncomplicated phacoemulsification in eyes with vitreomacular traction (VMT). This retrospective observational cohort study included consecutive patients with VMT undergoing cataract surgery. Clinical records and optical coherence tomography (OCT) images were reviewed for corrected distance visual acuity (CDVA), axial length, central subfield thickness (CST), VMT configuration and width, intraretinal fluid (IRF), subretinal fluid (SRF), cotton ball sign, postoperative cystoid macular oedema (CMO), VMT release, macular hole formation and subsequent vitrectomy. Multivariable logistic regression was used to assess factors associated with VMT-release. Two hundred and two eyes of 202 patients were included (mean age, 77.1 ± 6.7 years; mean follow-up, 7.3 ± 5.7 months). Postoperative CDVA improved to 0.15 ± 0.16 LogMAR (P < 0.01). CMO developed in 42 eyes (20.8%) and occurred in 15 of 95 eyes receiving ketorolac (15.8%) and 27 of 107 eyes not receiving ketorolac (25.2%, χ² = 2.73, P = 0.099; OR 0.56, 95% CI 0.28-1.12). VMT-release occurred in 14 eyes (6.9%) and macular hole occurred in 6 eyes (3.0%). The presence of IRF, SRF, or cotton ball sign was associated with VMT-release (χ² = 6.83, P = 0.009), whereas age, AL, CST, VMT-morphology and VMT-width were not. Six eyes (3.0%) required secondary vitrectomy. Standalone cataract surgery was associated with improved CDVA and low rates of postoperative macular hole formation and secondary vitrectomy in eyes with VMT. However, postoperative CMO was common, occurring in approximately one-fifth of eyes.

PMID 43052415
阅读全文 →
PubMedJournal of translational medicine2026-11-19

In vitro biological evaluation of a water-soluble hyperbranched β-cyclodextrin nanocarrier for co-delivery of doxorubicin and curcumin.

Samadzadeh Meisam M, Salmanifard Ardestani Mohammad Taha MT, Zarepour Atefeh A, Khosravi Arezoo A et al.

Conventional chemotherapy is often limited by poor aqueous solubility, systemic toxicity, and low bioavailability. To address these limitations, a water-dispersible hyperbranched β-cyclodextrin (HBCD) crosslinked with 1,2,3,4-butanetetracarboxylic acid (BTCA) was developed as a nanocarrier for the co-delivery of doxorubicin (DOX) and curcumin (CUR). HBCD was synthesized under optimized conditions and characterized using complementary physicochemical techniques. DOX and CUR were loaded individually and in combination, and drug release kinetics were evaluated. Biological performance was assessed by hemolysis, cytocompatibility, cellular uptake assessment, apoptosis analyses, anticancer activity, and concentration-dependent drug interaction analysis using SynergyFinder+. The optimized HBCD exhibited favorable physicochemical properties and excellent water solubility. Encapsulation efficiencies in the co-loaded formulation reached 50.8% for DOX and 45.7% for CUR. Drug release showed an initial burst followed by sustained release over 96 h, with kinetics best described by the Korsmeyer-Peppas model. HBCD demonstrated excellent hemocompatibility (<2% hemolysis) and high cytocompatibility toward HDF cells. Drug-loaded formulations produced concentration-dependent cytotoxicity in cancer cell lines. Cellular association and apoptosis analyses confirmed the biological activity of the formulations, while SynergyFinder+ indicated predominantly additive drug interactions with localized concentration-dependent positive interaction regions rather than uniform synergism. BTCA-crosslinked water-dispersible HBCD provides an effective platform for the co-delivery of hydrophilic and hydrophobic anticancer agents, combining efficient drug loading, sustained release, hemocompatibility, and encouraging in vitro biological performance. These findings establish a foundation for future mechanistic, pharmacokinetic, and in vivo studies to further evaluate the translational potential of this delivery system.

PMID 43053162
阅读全文 →
PubMedMethods in molecular biology (Clifton, N.J.)2026-11-19

Brain-Computer Interface: Exploring Alternative Solutions for Neurological Disorders.

Liu Xinhe X, Dai Ji J

Brain-computer interface (BCI) refers to a system that enables direct communication between the brain and external devices. Although the concept of BCI was introduced over 50 years ago, recent advancements in hardware technology and decoding algorithms have accelerated its development significantly. In the realm of neurological disorders, BCI has shown great potential as a tool for diagnosis, treatment, rehabilitation, and functional compensation. This chapter provides a comprehensive review of BCI applications in neurological disorders, covering aspects such as diagnosis and prognosis, therapeutic interventions, rehabilitation strategies, and restoration of impaired functions. These developments highlight the practicality and effectiveness of BCI in offering adaptable solutions for patients with neurological conditions. Nonetheless, further research is essential to address ongoing technical, clinical, and ethical challenges to fully realize the potential of BCI technology.

PMID 43052670
阅读全文 →
PubMedRNA biology2026-11-19

The venom-gland small RNA transcriptome of the centipede Scolopendra subspinipes mutilans across the venom-release cycle.

Zhao Juan J, Zhao Fang F, Li Yonghong Y, Zhang Wuqiong W et al.

Venom production in centipedes is cyclical, but the small RNA content of the venom gland and its changes across the venom-release cycle have not been described. We sequenced nine small RNA libraries from venom glands of Scolopendra subspinipes mutilans, three at each of three stages: before release, and 0 h and 1 h after electrically induced venom release, and analysed the deposited reads with an open pipeline. miRNAs accounted for 47.6-65.2% of reads. Reads matched 52 conserved miRNA families with arthropod members, including the mandibulate-specific miR-965 and miR-282 and miR-125, which has not been found in the genome of the centipede Strigamia maritima. Reads of 24-30 nt outside known non-coding RNA classes made up 8.4-25.9% of each library; they were biased towards a 5' uridine, showed a strong ping-pong signature and, in a post hoc analysis, came preferentially from transcripts resembling transposable-element proteins, indicating piRNA-like small RNAs in this somatic tissue. No miRNA unit met the differential-abundance criteria of both DESeq2 and edgeR. For 53-65 of 272 miRNA units per comparison, the confidence interval excluded changes of two-fold or more, and simulations indicated that three libraries per stage detect a two-fold change with 14% power. novel-miR34, a predicted novel miRNA whose precursor lies within a transcript annotated as a CAP-superfamily venom allergen, was not significantly altered. A survey of 9,485 NCBI protein records annotated as venom allergens showed that this label is applied across many taxa. These data provide a replicated small RNA resource for a myriapod venom gland.

PMID 43053351
阅读全文 →
PubMedHealth research policy and systems2026-11-19

Policy options for strengthening health technology assessment in Iran.

Bashzar Salman S, Yazdi-Feyzabadi Vahid V, Mohseni Mohammad M, Sabermahani Asma A

Health technology-related challenges continue to place pressure on health systems, making the effective use of health technology assessment (HTA) essential for evidence-informed decision-making. Despite more than a decade since the establishment of HTA within the Iranian health system, its institutional arrangements remain fragmented and insufficiently coordinated. Multiple HTA units operate without a unified policy framework, resulting in weak alignment between HTA bodies and decision-making entities, as well as limited transparency and accountability in performance. This study aimed to identify and comparatively assess policy options for strengthening the governance, coordination and effectiveness of HTA in Iran. The research specifically addressed: (1) how existing HTA structures function and interact and (2) what feasible policy options can improve coherence, performance and policy impact. We conducted a multiphase policy analysis comprising four stages: (1) comparative analysis of international HTA models, (2) literature review, (3) qualitative policy analysis and (4) synthesis and validation. Data were collected through semi-structured interviews with key informants and document analysis, followed by focus group discussions to refine and validate policy options. The integration of findings across phases informed the development and comparative assessment of policy options using explicit criteria. Three policy options were identified and systematically refined: maintaining the current structure through the implementation of a comprehensive coordination strategy; establishing a centralized higher institution under the direct authority of the Ministry of Health and Medical Education (MoHME), supported by specialized committees within the deputies of MoHME; and creating an independent HTA body outside MoHME within the national technology governance system. Each option was comparatively assessed in terms of feasibility, effectiveness and sustainability, highlighting key tradeoffs. The findings suggest that whilst centralized models may enhance coordination, independent structures may improve transparency and reduce conflicts of interest. A coherent and responsive HTA system in Iran requires structural reform combined with clear governance mechanisms and stakeholder alignment. A phased or hybrid approach may offer a pragmatic pathway to balance feasibility with long-term system performance. The study provides actionable policy recommendations to strengthen HTA institutionalization and its impact on health system decision-making.

PMID 43053116
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多abuse-deterrent extended release tablet technology